nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—CYP1A1—polycystic ovary syndrome	0.508	1	CbGaD
Nifedipine—Gastrointestinal tract irritation—Metformin—polycystic ovary syndrome	0.00781	0.0735	CcSEcCtD
Nifedipine—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.00474	0.0446	CcSEcCtD
Nifedipine—CYP1A2—urine—polycystic ovary syndrome	0.00412	0.032	CbGeAlD
Nifedipine—Heartburn—Metformin—polycystic ovary syndrome	0.00405	0.0381	CcSEcCtD
Nifedipine—CYP2C9—urine—polycystic ovary syndrome	0.00391	0.0304	CbGeAlD
Nifedipine—CYP2E1—urine—polycystic ovary syndrome	0.00371	0.0288	CbGeAlD
Nifedipine—Rigors—Metformin—polycystic ovary syndrome	0.00342	0.0321	CcSEcCtD
Nifedipine—CYP3A4—urine—polycystic ovary syndrome	0.00298	0.0232	CbGeAlD
Nifedipine—CYP2D6—urine—polycystic ovary syndrome	0.00293	0.0228	CbGeAlD
Nifedipine—Lightheadedness—Metformin—polycystic ovary syndrome	0.0025	0.0235	CcSEcCtD
Nifedipine—CACNA1D—adrenal cortex—polycystic ovary syndrome	0.00232	0.018	CbGeAlD
Nifedipine—CACNA1H—uterus—polycystic ovary syndrome	0.00231	0.0179	CbGeAlD
Nifedipine—CACNA1H—pituitary gland—polycystic ovary syndrome	0.00227	0.0176	CbGeAlD
Nifedipine—Nasal congestion—Metformin—polycystic ovary syndrome	0.00222	0.0209	CcSEcCtD
Nifedipine—CACNB2—pituitary gland—polycystic ovary syndrome	0.00214	0.0166	CbGeAlD
Nifedipine—Renal impairment—Metformin—polycystic ovary syndrome	0.00213	0.02	CcSEcCtD
Nifedipine—CACNA1H—adrenal gland—polycystic ovary syndrome	0.00203	0.0157	CbGeAlD
Nifedipine—Pain in extremity—Metformin—polycystic ovary syndrome	0.00202	0.019	CcSEcCtD
Nifedipine—Nicardipine—ADRA1D—polycystic ovary syndrome	0.00201	0.362	CrCbGaD
Nifedipine—CACNA2D1—adipose tissue—polycystic ovary syndrome	0.002	0.0156	CbGeAlD
Nifedipine—Migraine—Metformin—polycystic ovary syndrome	0.00199	0.0187	CcSEcCtD
Nifedipine—ABCC3—adrenal cortex—polycystic ovary syndrome	0.00195	0.0151	CbGeAlD
Nifedipine—CACNB2—adrenal gland—polycystic ovary syndrome	0.00191	0.0149	CbGeAlD
Nifedipine—CACNA1H—female gonad—polycystic ovary syndrome	0.00189	0.0147	CbGeAlD
Nifedipine—CACNA1D—pituitary gland—polycystic ovary syndrome	0.00187	0.0145	CbGeAlD
Nifedipine—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00187	0.0145	CbGeAlD
Nifedipine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00187	0.0176	CcSEcCtD
Nifedipine—Breast disorder—Metformin—polycystic ovary syndrome	0.00183	0.0172	CcSEcCtD
Nifedipine—Cramp muscle—Metformin—polycystic ovary syndrome	0.00182	0.0172	CcSEcCtD
Nifedipine—CACNA2D1—adrenal gland—polycystic ovary syndrome	0.0018	0.014	CbGeAlD
Nifedipine—CALM3—adrenal cortex—polycystic ovary syndrome	0.00179	0.0139	CbGeAlD
Nifedipine—CACNB2—vagina—polycystic ovary syndrome	0.00177	0.0138	CbGeAlD
Nifedipine—Abdominal distension—Metformin—polycystic ovary syndrome	0.00176	0.0166	CcSEcCtD
Nifedipine—CACNA1H—endocrine gland—polycystic ovary syndrome	0.00176	0.0136	CbGeAlD
Nifedipine—CACNA1C—pituitary gland—polycystic ovary syndrome	0.00173	0.0134	CbGeAlD
Nifedipine—CACNA1C—adipose tissue—polycystic ovary syndrome	0.00172	0.0134	CbGeAlD
Nifedipine—CALM2—embryo—polycystic ovary syndrome	0.00172	0.0133	CbGeAlD
Nifedipine—Nicardipine—ADRA1B—polycystic ovary syndrome	0.00172	0.309	CrCbGaD
Nifedipine—CALM1—embryo—polycystic ovary syndrome	0.00171	0.0133	CbGeAlD
Nifedipine—Sweating increased—Metformin—polycystic ovary syndrome	0.0017	0.016	CcSEcCtD
Nifedipine—Angina pectoris—Metformin—polycystic ovary syndrome	0.0017	0.016	CcSEcCtD
Nifedipine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00168	0.0158	CcSEcCtD
Nifedipine—CACNA2D1—female gonad—polycystic ovary syndrome	0.00168	0.013	CbGeAlD
Nifedipine—CACNA1D—adrenal gland—polycystic ovary syndrome	0.00167	0.013	CbGeAlD
Nifedipine—CYP2A6—adipose tissue—polycystic ovary syndrome	0.00167	0.013	CbGeAlD
Nifedipine—CACNA2D1—vagina—polycystic ovary syndrome	0.00167	0.0129	CbGeAlD
Nifedipine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00163	0.0153	CcSEcCtD
Nifedipine—CALM3—endometrium—polycystic ovary syndrome	0.0016	0.0124	CbGeAlD
Nifedipine—ABCC3—adipose tissue—polycystic ovary syndrome	0.00157	0.0122	CbGeAlD
Nifedipine—CACNA2D1—endocrine gland—polycystic ovary syndrome	0.00156	0.0121	CbGeAlD
Nifedipine—CACNA1C—adrenal gland—polycystic ovary syndrome	0.00154	0.012	CbGeAlD
Nifedipine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00148	0.0139	CcSEcCtD
Nifedipine—CALM3—uterus—polycystic ovary syndrome	0.00147	0.0114	CbGeAlD
Nifedipine—CACNA1D—endocrine gland—polycystic ovary syndrome	0.00145	0.0113	CbGeAlD
Nifedipine—CALM3—pituitary gland—polycystic ovary syndrome	0.00145	0.0112	CbGeAlD
Nifedipine—CALM3—adipose tissue—polycystic ovary syndrome	0.00144	0.0112	CbGeAlD
Nifedipine—CACNA1C—vagina—polycystic ovary syndrome	0.00143	0.0111	CbGeAlD
Nifedipine—Bradycardia—Metformin—polycystic ovary syndrome	0.00143	0.0134	CcSEcCtD
Nifedipine—CALM2—adrenal cortex—polycystic ovary syndrome	0.00141	0.0109	CbGeAlD
Nifedipine—ABCC3—adrenal gland—polycystic ovary syndrome	0.00141	0.0109	CbGeAlD
Nifedipine—Rhinitis—Metformin—polycystic ovary syndrome	0.0014	0.0132	CcSEcCtD
Nifedipine—CALM1—adrenal cortex—polycystic ovary syndrome	0.0014	0.0109	CbGeAlD
Nifedipine—Hepatitis—Metformin—polycystic ovary syndrome	0.0014	0.0132	CcSEcCtD
Nifedipine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00139	0.0131	CcSEcCtD
Nifedipine—CYP2A6—vagina—polycystic ovary syndrome	0.00139	0.0108	CbGeAlD
Nifedipine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00138	0.013	CcSEcCtD
Nifedipine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00138	0.0129	CcSEcCtD
Nifedipine—CACNA1C—endocrine gland—polycystic ovary syndrome	0.00134	0.0104	CbGeAlD
Nifedipine—ABCC3—female gonad—polycystic ovary syndrome	0.00131	0.0102	CbGeAlD
Nifedipine—Eye disorder—Metformin—polycystic ovary syndrome	0.00131	0.0123	CcSEcCtD
Nifedipine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0013	0.0122	CcSEcCtD
Nifedipine—Flushing—Metformin—polycystic ovary syndrome	0.0013	0.0122	CcSEcCtD
Nifedipine—CALM3—adrenal gland—polycystic ovary syndrome	0.00129	0.01	CbGeAlD
Nifedipine—Angiopathy—Metformin—polycystic ovary syndrome	0.00127	0.012	CcSEcCtD
Nifedipine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00127	0.0119	CcSEcCtD
Nifedipine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00126	0.0119	CcSEcCtD
Nifedipine—CALM2—endometrium—polycystic ovary syndrome	0.00126	0.00976	CbGeAlD
Nifedipine—Chills—Metformin—polycystic ovary syndrome	0.00126	0.0118	CcSEcCtD
Nifedipine—CALM1—endometrium—polycystic ovary syndrome	0.00125	0.00971	CbGeAlD
Nifedipine—Erythema—Metformin—polycystic ovary syndrome	0.00122	0.0115	CcSEcCtD
Nifedipine—Malnutrition—Metformin—polycystic ovary syndrome	0.00122	0.0115	CcSEcCtD
Nifedipine—ABCC3—endocrine gland—polycystic ovary syndrome	0.00122	0.00946	CbGeAlD
Nifedipine—CALM3—female gonad—polycystic ovary syndrome	0.00121	0.00937	CbGeAlD
Nifedipine—Flatulence—Metformin—polycystic ovary syndrome	0.0012	0.0113	CcSEcCtD
Nifedipine—CALM3—vagina—polycystic ovary syndrome	0.0012	0.00931	CbGeAlD
Nifedipine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00119	0.0112	CcSEcCtD
Nifedipine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00117	0.011	CcSEcCtD
Nifedipine—CALM2—uterus—polycystic ovary syndrome	0.00116	0.00899	CbGeAlD
Nifedipine—Nicardipine—ADRA1A—polycystic ovary syndrome	0.00116	0.208	CrCbGaD
Nifedipine—CALM1—uterus—polycystic ovary syndrome	0.00115	0.00895	CbGeAlD
Nifedipine—Vision blurred—Metformin—polycystic ovary syndrome	0.00115	0.0108	CcSEcCtD
Nifedipine—Tremor—Metformin—polycystic ovary syndrome	0.00114	0.0107	CcSEcCtD
Nifedipine—CALM2—pituitary gland—polycystic ovary syndrome	0.00114	0.00883	CbGeAlD
Nifedipine—CALM2—adipose tissue—polycystic ovary syndrome	0.00113	0.00879	CbGeAlD
Nifedipine—CALM1—pituitary gland—polycystic ovary syndrome	0.00113	0.00879	CbGeAlD
Nifedipine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00113	0.0106	CcSEcCtD
Nifedipine—CALM1—adipose tissue—polycystic ovary syndrome	0.00113	0.00875	CbGeAlD
Nifedipine—ABCC2—adrenal gland—polycystic ovary syndrome	0.00112	0.00872	CbGeAlD
Nifedipine—Malaise—Metformin—polycystic ovary syndrome	0.0011	0.0103	CcSEcCtD
Nifedipine—Syncope—Metformin—polycystic ovary syndrome	0.00109	0.0103	CcSEcCtD
Nifedipine—Palpitations—Metformin—polycystic ovary syndrome	0.00108	0.0101	CcSEcCtD
Nifedipine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00107	0.0101	CcSEcCtD
Nifedipine—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00105	0.00812	CbGeAlD
Nifedipine—CYP2C8—endometrium—polycystic ovary syndrome	0.00104	0.00809	CbGeAlD
Nifedipine—Myalgia—Metformin—polycystic ovary syndrome	0.00104	0.00977	CcSEcCtD
Nifedipine—Chest pain—Metformin—polycystic ovary syndrome	0.00104	0.00977	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00103	0.0097	CcSEcCtD
Nifedipine—Discomfort—Metformin—polycystic ovary syndrome	0.00103	0.00965	CcSEcCtD
Nifedipine—CALM2—adrenal gland—polycystic ovary syndrome	0.00102	0.00789	CbGeAlD
Nifedipine—CALM1—adrenal gland—polycystic ovary syndrome	0.00101	0.00785	CbGeAlD
Nifedipine—Oedema—Metformin—polycystic ovary syndrome	0.000995	0.00936	CcSEcCtD
Nifedipine—Shock—Metformin—polycystic ovary syndrome	0.000979	0.00921	CcSEcCtD
Nifedipine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000976	0.00918	CcSEcCtD
Nifedipine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000974	0.00917	CcSEcCtD
Nifedipine—ABCC2—endocrine gland—polycystic ovary syndrome	0.000974	0.00756	CbGeAlD
Nifedipine—Skin disorder—Metformin—polycystic ovary syndrome	0.000967	0.00909	CcSEcCtD
Nifedipine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000962	0.00905	CcSEcCtD
Nifedipine—Anorexia—Metformin—polycystic ovary syndrome	0.000948	0.00892	CcSEcCtD
Nifedipine—CALM2—female gonad—polycystic ovary syndrome	0.000947	0.00735	CbGeAlD
Nifedipine—CALM1—female gonad—polycystic ovary syndrome	0.000943	0.00732	CbGeAlD
Nifedipine—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000943	0.00732	CbGeAlD
Nifedipine—CALM2—vagina—polycystic ovary syndrome	0.000942	0.00731	CbGeAlD
Nifedipine—CALM1—vagina—polycystic ovary syndrome	0.000937	0.00728	CbGeAlD
Nifedipine—Hypotension—Metformin—polycystic ovary syndrome	0.00093	0.00875	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000907	0.00853	CcSEcCtD
Nifedipine—Paraesthesia—Metformin—polycystic ovary syndrome	0.000894	0.00841	CcSEcCtD
Nifedipine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000887	0.00835	CcSEcCtD
Nifedipine—CYP1A1—uterus—polycystic ovary syndrome	0.000886	0.00688	CbGeAlD
Nifedipine—Somnolence—Metformin—polycystic ovary syndrome	0.000885	0.00832	CcSEcCtD
Nifedipine—CALM2—endocrine gland—polycystic ovary syndrome	0.000881	0.00684	CbGeAlD
Nifedipine—CALM1—endocrine gland—polycystic ovary syndrome	0.000877	0.00681	CbGeAlD
Nifedipine—Dyspepsia—Metformin—polycystic ovary syndrome	0.000876	0.00824	CcSEcCtD
Nifedipine—CYP1A1—adipose tissue—polycystic ovary syndrome	0.000866	0.00673	CbGeAlD
Nifedipine—Decreased appetite—Metformin—polycystic ovary syndrome	0.000865	0.00814	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000859	0.00808	CcSEcCtD
Nifedipine—Fatigue—Metformin—polycystic ovary syndrome	0.000858	0.00807	CcSEcCtD
Nifedipine—Constipation—Metformin—polycystic ovary syndrome	0.000851	0.00801	CcSEcCtD
Nifedipine—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000847	0.00658	CbGeAlD
Nifedipine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00082	0.00772	CcSEcCtD
Nifedipine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000814	0.00766	CcSEcCtD
Nifedipine—Urticaria—Metformin—polycystic ovary syndrome	0.00079	0.00744	CcSEcCtD
Nifedipine—Abdominal pain—Metformin—polycystic ovary syndrome	0.000787	0.0074	CcSEcCtD
Nifedipine—CYP2C8—vagina—polycystic ovary syndrome	0.00078	0.00606	CbGeAlD
Nifedipine—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000755	0.00586	CbGeAlD
Nifedipine—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00073	0.00567	CbGeAlD
Nifedipine—CYP1A1—female gonad—polycystic ovary syndrome	0.000725	0.00563	CbGeAlD
Nifedipine—CYP1A1—vagina—polycystic ovary syndrome	0.00072	0.00559	CbGeAlD
Nifedipine—Asthenia—Metformin—polycystic ovary syndrome	0.000714	0.00672	CcSEcCtD
Nifedipine—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000709	0.0055	CbGeAlD
Nifedipine—CYP3A5—female gonad—polycystic ovary syndrome	0.000709	0.0055	CbGeAlD
Nifedipine—CYP3A5—vagina—polycystic ovary syndrome	0.000704	0.00547	CbGeAlD
Nifedipine—Pruritus—Metformin—polycystic ovary syndrome	0.000704	0.00662	CcSEcCtD
Nifedipine—CYP2B6—vagina—polycystic ovary syndrome	0.0007	0.00543	CbGeAlD
Nifedipine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000683	0.0053	CbGeAlD
Nifedipine—ABCB1—embryo—polycystic ovary syndrome	0.000682	0.0053	CbGeAlD
Nifedipine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000681	0.00641	CcSEcCtD
Nifedipine—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000674	0.00523	CbGeAlD
Nifedipine—Amlodipine—CYP1A1—polycystic ovary syndrome	0.000669	0.121	CrCbGaD
Nifedipine—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000659	0.00512	CbGeAlD
Nifedipine—Dizziness—Metformin—polycystic ovary syndrome	0.000658	0.00619	CcSEcCtD
Nifedipine—CYP2B6—endocrine gland—polycystic ovary syndrome	0.000655	0.00508	CbGeAlD
Nifedipine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000649	0.00504	CbGeAlD
Nifedipine—Vomiting—Metformin—polycystic ovary syndrome	0.000633	0.00595	CcSEcCtD
Nifedipine—Rash—Metformin—polycystic ovary syndrome	0.000627	0.0059	CcSEcCtD
Nifedipine—Dermatitis—Metformin—polycystic ovary syndrome	0.000627	0.0059	CcSEcCtD
Nifedipine—Headache—Metformin—polycystic ovary syndrome	0.000623	0.00587	CcSEcCtD
Nifedipine—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000615	0.00477	CbGeAlD
Nifedipine—Nausea—Metformin—polycystic ovary syndrome	0.000591	0.00556	CcSEcCtD
Nifedipine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000559	0.00434	CbGeAlD
Nifedipine—CYP2D6—female gonad—polycystic ovary syndrome	0.000523	0.00406	CbGeAlD
Nifedipine—ABCB1—endometrium—polycystic ovary syndrome	0.000499	0.00388	CbGeAlD
Nifedipine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000495	0.00384	CbGeAlD
Nifedipine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000487	0.00378	CbGeAlD
Nifedipine—ABCB1—uterus—polycystic ovary syndrome	0.00046	0.00357	CbGeAlD
Nifedipine—ABCB1—pituitary gland—polycystic ovary syndrome	0.000452	0.00351	CbGeAlD
Nifedipine—ABCB1—adipose tissue—polycystic ovary syndrome	0.00045	0.00349	CbGeAlD
Nifedipine—ABCB1—adrenal gland—polycystic ovary syndrome	0.000404	0.00313	CbGeAlD
Nifedipine—ABCB1—female gonad—polycystic ovary syndrome	0.000376	0.00292	CbGeAlD
Nifedipine—ABCB1—vagina—polycystic ovary syndrome	0.000374	0.0029	CbGeAlD
Nifedipine—ABCB1—endocrine gland—polycystic ovary syndrome	0.00035	0.00272	CbGeAlD
Nifedipine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.22e-05	4.84e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—GHRL—polycystic ovary syndrome	1.21e-05	4.81e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.21e-05	4.81e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PLAT—polycystic ovary syndrome	1.21e-05	4.81e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.21e-05	4.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—VEGFA—polycystic ovary syndrome	1.2e-05	4.76e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.19e-05	4.75e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ATF1—polycystic ovary syndrome	1.19e-05	4.75e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	1.19e-05	4.73e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IRS2—polycystic ovary syndrome	1.19e-05	4.73e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CRP—polycystic ovary syndrome	1.19e-05	4.73e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	1.18e-05	4.69e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.18e-05	4.69e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.17e-05	4.65e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.16e-05	4.63e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.16e-05	4.62e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.16e-05	4.61e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—VEGFA—polycystic ovary syndrome	1.16e-05	4.61e-05	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—VEGFA—polycystic ovary syndrome	1.16e-05	4.61e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.16e-05	4.6e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	1.16e-05	4.6e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ATF1—polycystic ovary syndrome	1.15e-05	4.59e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.15e-05	4.59e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MTHFR—polycystic ovary syndrome	1.15e-05	4.59e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	1.15e-05	4.59e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.15e-05	4.58e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IRS2—polycystic ovary syndrome	1.15e-05	4.58e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IRS2—polycystic ovary syndrome	1.15e-05	4.58e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CRP—polycystic ovary syndrome	1.15e-05	4.58e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CRP—polycystic ovary syndrome	1.15e-05	4.58e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—GNAS—polycystic ovary syndrome	1.15e-05	4.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.13e-05	4.48e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.13e-05	4.48e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	1.12e-05	4.47e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	1.12e-05	4.45e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MTHFR—polycystic ovary syndrome	1.12e-05	4.44e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MTHFR—polycystic ovary syndrome	1.12e-05	4.44e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.11e-05	4.43e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—GNAS—polycystic ovary syndrome	1.11e-05	4.42e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—GNAS—polycystic ovary syndrome	1.11e-05	4.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NGFR—polycystic ovary syndrome	1.1e-05	4.38e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	1.1e-05	4.38e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	1.1e-05	4.37e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—IRS2—polycystic ovary syndrome	1.1e-05	4.37e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—POMC—polycystic ovary syndrome	1.09e-05	4.35e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—NCOR1—polycystic ovary syndrome	1.09e-05	4.35e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PRL—polycystic ovary syndrome	1.09e-05	4.34e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	1.09e-05	4.33e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	1.09e-05	4.33e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	1.07e-05	4.27e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.07e-05	4.26e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—INS—polycystic ovary syndrome	1.07e-05	4.25e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.07e-05	4.24e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	1.07e-05	4.24e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NGFR—polycystic ovary syndrome	1.07e-05	4.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.07e-05	4.24e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.06e-05	4.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—IRS2—polycystic ovary syndrome	1.06e-05	4.22e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—IRS2—polycystic ovary syndrome	1.06e-05	4.22e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—POMC—polycystic ovary syndrome	1.06e-05	4.21e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—POMC—polycystic ovary syndrome	1.06e-05	4.21e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—NCOR1—polycystic ovary syndrome	1.06e-05	4.21e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—NCOR1—polycystic ovary syndrome	1.06e-05	4.21e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.06e-05	4.21e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.06e-05	4.21e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PRL—polycystic ovary syndrome	1.06e-05	4.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PRL—polycystic ovary syndrome	1.06e-05	4.2e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.05e-05	4.18e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.05e-05	4.18e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	1.04e-05	4.15e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	1.04e-05	4.14e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IRS1—polycystic ovary syndrome	1.04e-05	4.13e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	1.04e-05	4.13e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.04e-05	4.12e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—CYP1A1—polycystic ovary syndrome	1.04e-05	4.12e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.04e-05	4.12e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.03e-05	4.11e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.02e-05	4.05e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.02e-05	4.05e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1e-05	3.99e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IRS1—polycystic ovary syndrome	1e-05	3.99e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IRS1—polycystic ovary syndrome	1e-05	3.99e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—CYP1A1—polycystic ovary syndrome	1e-05	3.99e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—CYP1A1—polycystic ovary syndrome	1e-05	3.99e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1e-05	3.98e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	1e-05	3.98e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1e-05	3.98e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	9.99e-06	3.97e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	9.99e-06	3.97e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	9.98e-06	3.97e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	9.96e-06	3.96e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	9.93e-06	3.95e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	9.85e-06	3.92e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	9.83e-06	3.91e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—INS—polycystic ovary syndrome	9.79e-06	3.89e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	9.77e-06	3.89e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	9.75e-06	3.88e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	9.73e-06	3.87e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	9.71e-06	3.86e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	9.69e-06	3.85e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—MTHFR—polycystic ovary syndrome	9.67e-06	3.84e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT2—polycystic ovary syndrome	9.61e-06	3.82e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—GNAS—polycystic ovary syndrome	9.6e-06	3.82e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—IRS1—polycystic ovary syndrome	9.59e-06	3.81e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	9.51e-06	3.78e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—MTHFR—polycystic ovary syndrome	9.35e-06	3.72e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—MTHFR—polycystic ovary syndrome	9.35e-06	3.72e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT2—polycystic ovary syndrome	9.3e-06	3.7e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT2—polycystic ovary syndrome	9.3e-06	3.7e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—GNAS—polycystic ovary syndrome	9.29e-06	3.69e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—GNAS—polycystic ovary syndrome	9.29e-06	3.69e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—IRS1—polycystic ovary syndrome	9.27e-06	3.69e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—IRS1—polycystic ovary syndrome	9.27e-06	3.69e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	9.22e-06	3.67e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	9.19e-06	3.65e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—INS—polycystic ovary syndrome	9.18e-06	3.65e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	9.17e-06	3.65e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.15e-06	3.64e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	9.11e-06	3.62e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	9.02e-06	3.59e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NRG1—polycystic ovary syndrome	8.98e-06	3.57e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	8.93e-06	3.55e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—INS—polycystic ovary syndrome	8.88e-06	3.53e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—INS—polycystic ovary syndrome	8.88e-06	3.53e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT2—polycystic ovary syndrome	8.87e-06	3.53e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.85e-06	3.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.85e-06	3.52e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	8.7e-06	3.46e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NRG1—polycystic ovary syndrome	8.68e-06	3.45e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NRG1—polycystic ovary syndrome	8.68e-06	3.45e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	8.6e-06	3.42e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT2—polycystic ovary syndrome	8.58e-06	3.41e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT2—polycystic ovary syndrome	8.58e-06	3.41e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	8.51e-06	3.38e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—SERPINE1—polycystic ovary syndrome	8.43e-06	3.35e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	8.41e-06	3.34e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—BCL2—polycystic ovary syndrome	8.4e-06	3.34e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	8.29e-06	3.3e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	8.28e-06	3.29e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	8.27e-06	3.29e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	8.2e-06	3.26e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	8.16e-06	3.25e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—SERPINE1—polycystic ovary syndrome	8.16e-06	3.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—SERPINE1—polycystic ovary syndrome	8.16e-06	3.24e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	8.13e-06	3.23e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—BCL2—polycystic ovary syndrome	8.12e-06	3.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—BCL2—polycystic ovary syndrome	8.12e-06	3.23e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	8.05e-06	3.2e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	7.94e-06	3.16e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—INS—polycystic ovary syndrome	7.9e-06	3.14e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	7.89e-06	3.14e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	7.87e-06	3.13e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	7.86e-06	3.13e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PPARG—polycystic ovary syndrome	7.84e-06	3.12e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	7.81e-06	3.11e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	7.78e-06	3.1e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	7.78e-06	3.09e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	7.76e-06	3.09e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	7.74e-06	3.08e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—INS—polycystic ovary syndrome	7.74e-06	3.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—POMC—polycystic ovary syndrome	7.73e-06	3.07e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—INS—polycystic ovary syndrome	7.72e-06	3.07e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	7.71e-06	3.07e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IRS2—polycystic ovary syndrome	7.69e-06	3.06e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—INS—polycystic ovary syndrome	7.69e-06	3.06e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	7.59e-06	3.02e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PPARG—polycystic ovary syndrome	7.58e-06	3.02e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PPARG—polycystic ovary syndrome	7.58e-06	3.02e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—LEP—polycystic ovary syndrome	7.53e-06	2.99e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—POMC—polycystic ovary syndrome	7.48e-06	2.97e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—POMC—polycystic ovary syndrome	7.48e-06	2.97e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—IL6—polycystic ovary syndrome	7.46e-06	2.97e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IRS2—polycystic ovary syndrome	7.44e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IRS2—polycystic ovary syndrome	7.44e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	7.44e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—INS—polycystic ovary syndrome	7.44e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—INS—polycystic ovary syndrome	7.44e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	7.41e-06	2.95e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	7.34e-06	2.92e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	7.34e-06	2.92e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	7.33e-06	2.91e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—INS—polycystic ovary syndrome	7.29e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—LEP—polycystic ovary syndrome	7.28e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—LEP—polycystic ovary syndrome	7.28e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—IL6—polycystic ovary syndrome	7.22e-06	2.87e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—IL6—polycystic ovary syndrome	7.22e-06	2.87e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	6.95e-06	2.76e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	6.9e-06	2.75e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	6.84e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	6.82e-06	2.71e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	6.73e-06	2.67e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IRS1—polycystic ovary syndrome	6.71e-06	2.67e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—INS—polycystic ovary syndrome	6.69e-06	2.66e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	6.62e-06	2.63e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	6.57e-06	2.61e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IRS1—polycystic ovary syndrome	6.49e-06	2.58e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IRS1—polycystic ovary syndrome	6.49e-06	2.58e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—POMC—polycystic ovary syndrome	6.46e-06	2.57e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—INS—polycystic ovary syndrome	6.43e-06	2.56e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	6.39e-06	2.54e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	6.27e-06	2.49e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—POMC—polycystic ovary syndrome	6.25e-06	2.49e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—POMC—polycystic ovary syndrome	6.25e-06	2.49e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—INS—polycystic ovary syndrome	6.22e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—INS—polycystic ovary syndrome	6.22e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IGF1—polycystic ovary syndrome	6.22e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT2—polycystic ovary syndrome	6.21e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.02e-06	2.39e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.02e-06	2.39e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.01e-06	2.39e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.01e-06	2.39e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	6.01e-06	2.39e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	5.94e-06	2.36e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.9e-06	2.35e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	5.86e-06	2.33e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	5.85e-06	2.33e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—INS—polycystic ovary syndrome	5.83e-06	2.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.71e-06	2.27e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.71e-06	2.27e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.6e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	5.55e-06	2.21e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	5.52e-06	2.2e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	5.49e-06	2.18e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	5.47e-06	2.18e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	5.44e-06	2.16e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.36e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.11e-06	2.03e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.84e-06	1.93e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—polycystic ovary syndrome	4.76e-06	1.89e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	4.74e-06	1.89e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	4.68e-06	1.86e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	4.65e-06	1.85e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.6e-06	1.83e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.6e-06	1.83e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.51e-06	1.8e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—polycystic ovary syndrome	4.34e-06	1.73e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—polycystic ovary syndrome	4.2e-06	1.67e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—polycystic ovary syndrome	4.2e-06	1.67e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.06e-06	1.62e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—polycystic ovary syndrome	4.01e-06	1.6e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.93e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.93e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—polycystic ovary syndrome	3.88e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—polycystic ovary syndrome	3.88e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.66e-06	1.46e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.61e-06	1.44e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.59e-06	1.43e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—polycystic ovary syndrome	2.81e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—polycystic ovary syndrome	2.72e-06	1.08e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—polycystic ovary syndrome	2.72e-06	1.08e-05	CbGpPWpGaD
